Skip to main content
. 2018 Jul 12;13:4107–4119. doi: 10.2147/IJN.S163929

Figure 8.

Figure 8

The tumor volume (A), body weight (B), and H and E staining of tumor tissue (C) analysis of MCF-7 ADR tumor-bearing BALB/c mice after intravenous administration of different formulations (saline, DNLC, LNLC and LDNLC). **P < 0.01 versus LDNLC. Data were expressed as mean ± SD (n = 6).

Abbreviations: DNLC, DOX mono-delivery NLC; LNLC, Lapa mono-delivery NLC; LDNLC, NLC co-delivering Lapa and DOX; DOX, doxorubicin; NLC, nanostructured lipid carrier; Lapa, β-lapachone.